| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol |
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇 |
164658-13-3 |
詳細(xì)
|
| OSTARINE(MK-2866) |
|
841205-47-8 |
詳細(xì)
|
| 4-Chloro-N-(2-((5-(trifluoromethyl)pyridin-2-yl)sulfonyl)ethyl)benzamide |
|
188591-46-0 |
詳細(xì)
|
| rel-2-(4-Chlorophenoxy)-2-methyl-N-((1S,2R)-5-(methylsulfonamido)adamantan-2-yl)propanamide |
|
878489-28-2 |
詳細(xì)
|
| N-(1,3-Diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide |
|
890764-36-0 |
詳細(xì)
|
| GNE 617 |
N-[[4-[(3,5-二氟苯基)磺?；鵠苯基]甲基]咪唑并[1,2-A]吡啶-6-甲酰胺 |
1362154-70-8 |
詳細(xì)
|
| ML216 |
N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲 |
1430213-30-1 |
詳細(xì)
|
| INK-1117 MLN1117 |
6-(2-氨基-5-苯并惡唑基)咪唑并[1,2-A]吡啶-3-基]-4-嗎啉基甲酮 |
1268454-23-4 |
詳細(xì)
|
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
詳細(xì)
|
| ETC-159 |
1,2,3,6-四氫-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-噠嗪基)-7H-嘌呤-7-乙酰胺 |
1638250-96-0 |
詳細(xì)
|
| 4-(2-Chloro-6-fluorobenzyl)-N-(furan-2-ylmethyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide |
|
702662-50-8 |
詳細(xì)
|
| GJ103 |
J103 游離 |
1459687-89-8 |
詳細(xì)
|
| 1883510-31-3 |
|
1883510-31-3 |
詳細(xì)
|
| Orelabrutinib |
奧布替尼 |
1655504-04-3 |
詳細(xì)
|
| (3-METHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID PINACOL ESTER |
|
1072811-91-6 |
詳細(xì)
|
| MAC-545496 |
|
838810-96-1 |
詳細(xì)
|
| THPP-1 |
|
1257051-63-0 |
詳細(xì)
|
| α,α-Diphenyl-4-[(3-pyridinylmethylene)amino]-1-piperazinepentanenitrile |
ALPHA,ALPHA-二苯基-4-[(3-吡啶亞甲基)氨基]-1-吡嗪戊腈 |
218136-59-5 |
詳細(xì)
|
| BI605906 |
化合物 T14567 |
960293-88-3 |
詳細(xì)
|
| PLpro inhibitor |
5-(乙酰氨基)-2-甲基-N-[(1R)-1-(1-萘基)乙基]苯甲酰胺 |
1093070-14-4 |
詳細(xì)
|
| BenzaMide, 5-broMo-N-[(1,2-dihydro-4,6-diMethyl-2-oxo-3-pyridinyl)Methyl]-3-[ethyl(tetrahydro-2H-pyran-4-yl)aMino]-2-Methyl- |
EPZ-6438中間體 |
1403257-80-6 |
詳細(xì)
|
| ML418 |
|
1928763-08-9 |
詳細(xì)
|
| FB23 |
|
2243736-35-6 |
詳細(xì)
|
| Insulin-like Growth Factor-1 Receptor Inhibitor |
胰島素樣生長(zhǎng)因子-1 受體拮抗劑 |
468740-43-4 |
詳細(xì)
|
| TCN-201 |
|
852918-02-6 |
詳細(xì)
|
| PEXMETINIB |
|
945614-12-0 |
詳細(xì)
|
| 865285-29-6 |
|
865285-29-6 |
詳細(xì)
|
| Mebeverine hydrochloride |
|
2753-45-9 |
詳細(xì)
|
| MS049 (hydrochloride) |
|
2095432-59-8 |
詳細(xì)
|
| N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
|
342641-94-5 |
詳細(xì)
|
| 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide |
3-氰基-N-(1,3-二苯基吡唑-5-基)苯甲酰胺 |
781652-57-1 |
詳細(xì)
|
| EGFR inhibitor |
|
879127-07-8 |
詳細(xì)
|
| DB-07268 |
2-[[2-[(3-羥基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺 |
929007-72-7 |
詳細(xì)
|
| 2002381-25-9 |
|
2002381-25-9 |
詳細(xì)
|
| T5601640 |
|
924473-59-6 |
詳細(xì)
|
| LIT-001 |
化合物L(fēng)IT-001 |
2245072-21-1 |
詳細(xì)
|
| ATP synthase inhibitor 1 |
|
1023043-30-2 |
詳細(xì)
|
| EZH2-A€IN-A€2 |
|
2238821-31-1 |
詳細(xì)
|
| VUN65671 |
|
2479465-67-1 |
詳細(xì)
|
| 680C91 |
|
163239-22-3 |
詳細(xì)
|
| AGI6780 |
|
1432660-47-3 |
詳細(xì)
|
| SR9009 |
|
1379686-30-2 |
詳細(xì)
|
| 1025015-40-0 |
|
1025015-40-0 |
詳細(xì)
|
| Wnt Agonist |
WNT AGONIST 1 (CID11210285 鹽酸鹽) |
853220-52-7 |
詳細(xì)
|
| 5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide |
|
1093070-16-6 |
詳細(xì)
|
| APS-2-79 |
APS-2-79 鹽酸鹽 |
2002381-31-7 |
詳細(xì)
|
| ALPHA-(4-CHLOROPHENYL)-4-[(4-FLUOROPHENYL)METHYL]-1-PIPERIDINEETHANOL |
依利羅地 |
119431-25-3 |
詳細(xì)
|
| PF-06446846 HYDROCHLORIDE |
|
1632250-50-0 |
詳細(xì)
|
| C12-13 pareth-3 |
|
2408648-20-2 |
詳細(xì)
|
| GNF-2 |
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 |
778270-11-4 |
詳細(xì)
|
| 6-(5-Bromo-2-hydroxyphenyl)-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrile |
|
491871-58-0 |
詳細(xì)
|
| KGN |
2-([1,1-聯(lián)苯]-4-基氨基甲酰)苯甲酸 |
4727-31-5 |
詳細(xì)
|
| EI1 |
6-氰基-N-[(1,2-二氫-4,6-二甲基-2-氧代-3-吡啶基)甲基]-1-(1-乙基丙基)-1H-吲哚-4-甲酰胺 |
1418308-27-6 |
詳細(xì)
|
| TAK-632 |
|
1228591-30-7 |
詳細(xì)
|
| VPS34 |
|
1383716-46-8 |
詳細(xì)
|
| 825658-06-8 |
化合物ML335 |
825658-06-8 |
詳細(xì)
|
| RU-301 |
|
1110873-99-8 |
詳細(xì)
|
| 1815580-06-3 |
|
1815580-06-3 |
詳細(xì)
|
| BC-DXI-843 |
化合物BC-DXI-843 |
2421117-98-6 |
詳細(xì)
|
| GOT1 inhibitor 2c |
N-(4-氯苯基)-4-(1H-吲哚-4-基)哌嗪-1-甲酰胺 |
732973-87-4 |
詳細(xì)
|
| mebeverine alcohol |
酒美貝維林 |
14367-47-6 |
詳細(xì)
|
| SKLB 610 |
|
1125780-41-7 |
詳細(xì)
|
| RAF709 |
化合物RAF709 |
1628838-42-5 |
詳細(xì)
|
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
詳細(xì)
|
| SB 4 |
|
100874-08-6 |
詳細(xì)
|
| UT-34 |
|
2168525-92-4 |
詳細(xì)
|
| Pyrazinecarboxamide, 3-amino-6-chloro-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]-4-piperidinyl]-3-ethyl-1-piperazinyl]- (9CI) |
3-氨基-6-氯-5-[(3S)-4-[1-[(4-氯苯基)甲基]-4-哌啶基]-3-乙基-1-哌嗪基]-2-哌嗪甲酰胺 |
906805-42-3 |
詳細(xì)
|
| SC-1 |
|
1313019-65-6 |
詳細(xì)
|
| AIM-100 |
5,6-二苯基-N-[[(2S)-四氫-2-呋喃基]甲基]呋喃并[2,3-D]嘧啶-4-胺 |
873305-35-2 |
詳細(xì)
|
| UNC-926 Hydochloride |
|
1184136-10-4 |
詳細(xì)
|
| RG3039 |
5-[[1-(2,6-二氯芐基)哌啶-4-基]甲氧基]喹唑啉-2,4-二胺 |
1005504-62-0 |
詳細(xì)
|
| SGC707 |
N-6-異喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1687736-54-4 |
詳細(xì)
|
| 7-DICHLORO-2-DIMETHYLAMINOMETHYL-QUINOLIN-8-OL |
化合物PBT-1033 |
747408-78-2 |
詳細(xì)
|
| 1027847-67-1 |
|
1027847-67-1 |
詳細(xì)
|
| 2095704-43-9 |
|
2095704-43-9 |
詳細(xì)
|
| 2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide |
|
425613-09-8 |
詳細(xì)
|
| PZ-2891 |
|
2170608-82-7 |
詳細(xì)
|
| ML417 |
|
1386162-69-1 |
詳細(xì)
|
| 3-Pyridinecarboxamide, 2-amino-5-[3-(1-piperazinyl)phenyl]-N-4-pyridinyl- |
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)煙酰胺 |
2328094-11-5 |
詳細(xì)
|
| 1-(2,6-Dibromo-4-isopropylphenyl)-3-(pyridin-3-yl)urea |
|
688309-70-8 |
詳細(xì)
|
| RU-302 |
|
1182129-77-6 |
詳細(xì)
|
| RET V804M-IN-1 |
化合物RET V804M-IN-1 |
2414909-94-5 |
詳細(xì)
|
| 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione |
3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮 |
425637-18-9 |
詳細(xì)
|
| KY0211 |
|
1118807-13-8 |
詳細(xì)
|
| CDN 1163 |
4-異丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺 |
892711-75-0 |
詳細(xì)
|
| 2-Fluoro-N-(3-fluoro-5-pyridin-2-yl-benzoyl)-benzenesulfonhydrazine |
化合物WM-1119 |
2055397-28-7 |
詳細(xì)
|
| TH 257 |
|
2244678-29-1 |
詳細(xì)
|
| 1111556-37-6 |
|
1111556-37-6 |
詳細(xì)
|
| iGOT1-01 |
化合物IGOT1-01 |
882256-55-5 |
詳細(xì)
|
| VU6015929 |
|
|
詳細(xì)
|
| 1-(4-CHLORO-BENZYL)-1 H-INDOLE-3-CARBALDEHYDE |
1-(4-氯芐基)-1H-吲哚-3-甲醛 |
75629-57-1 |
詳細(xì)
|
| CID 1375606 |
|
313493-80-0 |
詳細(xì)
|
| 4-[5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE |
4-(5-(4-氯苯基)-3-(三氟甲基)-1H- |
170569-86-5 |
詳細(xì)
|
| NCGC00378430 |
|
|
詳細(xì)
|
| ASP 7663;ASP-7663;ASP7663 |
|
1190217-35-6 |
詳細(xì)
|
| N~2~-[(3,4-dimethoxyphenyl)sulfonyl]-N-(2,6-dimethylphenyl)-N~2~-(2-phenylethyl)glycinamide |
|
439940-12-2 |
詳細(xì)
|
| Benzoic acid, 4-[[(cyclopropylmethyl)[4-(2-fluorophenoxy)benzoyl]amino]methyl]- |
化合物TAK-615 |
1664335-55-0 |
詳細(xì)
|
| CHEMBL159279 |
|
305339-41-7 |
詳細(xì)
|
| BenzaMide, N-[4-chloro-3-(trifluoroMethyl)phenyl]-2-[2-(diMethylaMino)ethoxy]-6-ethoxy- |
|
1311423-89-8 |
詳細(xì)
|
| NS 11394 |
3'-[5-(1-羥基-1-甲基乙基)-1H-苯并咪唑-1-基]-[1,1'-聯(lián)苯]-2-甲腈 |
951650-22-9 |
詳細(xì)
|